Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity
and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of …

Microbial biofilms are the cause of persistent infections associated with various medical
implants and distinct body sites such as the urinary tract, lungs, and wounds. Compared with …

The development of therapies that modulate or prevent pathogen virulence may be a key
strategy for circumventing antimicrobial resistance. Toward that end, we examined the …

Bacterial biofilms remain a persistent threat to human healthcare due to their role in the
development of antimicrobial resistance. To combat multi-drug resistant pathogens, it is …

Bacterial biofilms are major contributors to chronic infections in humans. Because they are
recalcitrant to conventional therapy, they present a particularly difficult treatment challenge …

Antibiotic resistance in Pseudomonas aeruginosa remains one of the most challenging
phenomena of everyday medical science. The universal spread of high-risk clones of …

Pyoverdines (PVDs) are a class of siderophores produced mostly by members of the genus
Pseudomonas. Their primary function is to accumulate, mobilize, and transport iron …

Clinically significant pathogens such as Pseudomonas aeruginosa evade the effects of
antibiotics using quorum sensing (QS) systems, making antimicrobial resistance (AMR) a …

One of the challenges associated with the treatment of Pseudomonas aeruginosa infections
is the high prevalence of multidrug resistance (MDR). Since conventional antibiotics are …

Pseudomonas aeruginosa is an opportunistic human pathogen responsible for acute and
chronic, hard to treat infections. Persistence of P. aeruginosa is due to its ability to develop …